CytoMed Expands Research Collaboration Into China After Entering Into MOU With China-Based Hangzhou CNK Therapeutics Co., Ltd.
CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "the Company"), a Singapore biopharmaceutical company focused on utilizing its licensed proprietary tech to create novel allogeneic